Comparison of different surgical techniques in the treatment of pterygium
Pterjium tedavisinde farklı cerrahi tekniklerin karşılaştırılması
Abstract views: 74 / PDF downloads: 69
DOI:
https://doi.org/10.5455/GMJ-30-2012-108Keywords:
Mitomycin C, recurrence, pterygiumAbstract
This study was done to compare the rates of recurrence of pterygium following performed different surgical techniques for treatment. One hundred and thirty eyes of 128 patients were examined following the surgical treatment in our clinic between February 2004- January 2008 with mean follow-up of six months. We performed bare sclera, application of intraoperative MMC (Mitomycin C), wide tenon’s membrane excision and conjunctival auto-grafting techniques. The age and sex of the patients and follow-up duration, operation techniques, complications and the recurrence times were noted. Median follow-up was 9,42±3,93 months and the recurrence rate was %25,4. The highest recurrence rate was %55,2 (in the bare sclera technique), the lowest recurrence rate was %13,5 (in the intraoperative MMC technique). It was %14,6 in conjunctival auto-grafting technique group and %31,3 in the complete tenon’s membrane excision group. Statistically, the rate of recurrence was meaningful between the bare sclera group and the conjunctival autografting group and between intraoperative MMC group. But the outcomes of the wide tenon’s membrane excision group and the other three groups weren’t meaningful. Bare sclera technique had the highest recurrence rates. Though, there wasn’t meaningful recurrence rates between intraoperative MMC technique and the conjunctival auto-grafting technique, we must prefer the second one because of its lowest complication risks. The wide tenon’s membrane excision technique needs some more studies to compare the others.
Metrics
References
McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol. 2000;84(3):289-92.
Threlfall TJ, English DR.Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol 1999;128(3):280- 7.
Hirst LW, Sebban A, Chant D. Pterygium recurrence time. Ophthalmology 1994;101(4):755-8.
Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 1995;120(2):151-60.
Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 1997;115(10):1235-40. Erratum in: Arch Ophthalmol 1998 Apr;116(4):552.
Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997;104(6):974-85.
Taylor HR, West S, Muñoz B, Rosenthal FS, Bressler SB, Bressler NM. The long-term effects of visible light on the eye. Arch Ophthalmol 1992;110(1):99-104.
Anduze AL. Merest sclera technique for primary pterygium surgery. Ophthalmic Surg 1989;20(12):892-4.
Riordan-Eva P, Kielhorn I, Ficker LA, Steele AD, Kirkness CM. Conjunctival autografting in the surgical management of pterygium Eye 1993;7:634-8.
Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95(6):813-21.
Mikaniki E, Rasolinejad SA. Simple excision alone versus simple excision plus mitomycin C in the treatment of pterygium. Ann Saudi Med 2007;27(3):158-60.
Saifuddin S, Baum KL. Recurrent pterygia. laser therapy: a preliminary report. Indian J Ophthalmol 1993;41(1):17-9.
Cano-Parra J, Diaz-Llopis M, Maldonado MJ, Vila E, Menezo JL. Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol 1995;79(5):439-41.
Alsagoff Z, Tan DT, Chee SP. Necrotising scleritis after bare sclera excision of pterygium. Br J Ophthalmol 2000;84(9):1050- 2.
Kenyon KR, Wagoner MD, Hettinger ME.Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985;92(11):1461-70.
Hirst LW. The Treatment Of Pterygium. Survey of Ophthalmology 2003;48:145-180.
Riordan-Eva P, Kielhorn I, Ficker LA, Steele AD, Kirkness CM. Conjunctival autografting in the surgical management of pterygium Eye 1993;7:634-8.
Altıparmak UE, Katırcıoğlu YA, Duman S. Nüks pterjium olgularında intraoperatif düşük doz mitomisin C ile kombine konjonktival otogreft tedavisi. [Conjunctival autograft treatment combined with intraoperative low dose mitomycin C in patients with recurrent pterygium] MN oftalmoloji 2000;7: 61-4.
Chan CM, Chew PT, Alsagoff Z, Wong JS, Tan DT. Vascular patterns in pterygium and conjunctival autografting: a pilot study using indocyanine green anterior segment angiography. Br J Ophthalmol 2001;85(3):350-3.
Ma DHK, See LC, Liau SB, Tsai RJF. Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol 2000;84:973-8.
Kenyon KR, Wagoner MD, Hettinger ME.Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985;92(11):1461-70.
Waller SG, Adamis AP. Pterygium. Chapter 35 Vol 6.Tasman W, Jaeger EA. Duane’s Ophthalmology on CD-ROM. 2006 Edition. Lippincott Williams&Wilkins.
Starck T, Kenyon KR, Serrano F. Conjunctival autograft for primary and recurrent pterygia: surgical technique and problem management Cornea 1991;10(3):196-202.
Wong VA, Law FC. Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians. Ophthalmology 1999;106(8):1512-5.
Kunitomo N, Mori S. Studies on the pterygium. Report 4. A treatment of the pterygium by mitomycin C instillation. Acta Soc Ophthalmol Jpn 1963;67:601-7.
Lam DSC, Wong AKK, Fan DSP, Chew S, Kwok PSK, Tso MOM. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: A 30 month follow-up study. Ophthalmology 1998;105:901-5.
Anduze AL, Burnett JM. Indications for and complications of mitomycin-C in pterygium surgery. Ophthalmic Surg Lasers 1996;27(8):667-73.
Sánchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol 1998;82(6):661-5.
Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea 1994;13(5):411-3.
Özyılkan A, Akova Y, Onat M, Aslan BS, Duman S. Pterjium tedavisinde intraoperatif mitomisin uygulaması. [Intraoperative application of mitomycin in the treatment of Pterjium.] 28. Ulusal Türk Oftalmoloji Kongresi Bülteni 1994;3:735-6.
Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99(11):1645-6.
Sak A, Karakaş N, Söker S. Nüks pterjiumlu olgularda mitomisin C kullanımı [The use of mitomycin C in patients with recurrent pterjium]. MN Oftalmoloji 1996;3: 345-6.
Durukan A, Doğan H. Pterjium eksizyonundan sonra mitomisin C uygulama sonuçları [Results of application of mitomycin C after excision of Pterjium]. MN Oftalmoloji 1998;5: 262-4.
Kammoun B, Kharrat W, Zouari K, Zribi W, Kemiha N, Fourati M, et al. [Pterygium: surgical treatment]. J Fr Ophtalmol 2001;24(8):823-8.
Avisar R, Bar S, Weinberger D. Preoperative injection of mitomycin C in combined pterygium and cataract surgery. Cornea. 2005 May;24(4):406-9.
Levy RL, Naidu S, Jacobson L. Safety and efficacy of the technique of complete tenon's membrane excision and mitomycin C in pterygium surgery. Eye Contact Lens 2005;31(3):105-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.